MYH14 and Huntington disease: Mechanistic investigations revealed reduced expression of GPIb and GPIIbIIIa-receptors—crucial for platelet adhesion and aggregation [28]—as well as impaired actin and myosin activity in platelets from patients receiving HD treatment [29].